OnKure Therapeutics, Inc. (OKUR) vs Polaryx Therapeutics, Inc. Common Stock (PLYX)

A side-by-side comparison of OnKure Therapeutics, Inc. and Polaryx Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
OnKure Therapeutics, Inc. logo
OKUR
OnKure Therapeutics, Inc.
$102M
$2.53HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
Polaryx Therapeutics, Inc. Common Stock logo
PLYX
Polaryx Therapeutics, Inc. Common Stock
$104M
$2.09HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT

Total return — OKUR vs PLYX

growth of $100 · dividends reinvested · last 1y
OKUR -0.4% (-0.4%/yr)PLYX -94.1% (-94.1%/yr)OKUR compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100$100$6
OKUR PLYX

OKUR vs PLYX: by the numbers

  • •PLYX is the larger company ($104M vs $102M market cap).

Metrics side by side

Valuation

MetricOKURPLYX
P/B ratio0.609.52

Profitability

MetricOKURPLYX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-34.11%-62.61%
ROIC-35.98%-47.75%

Growth (annualized)

MetricOKURPLYX
Total return CAGR (5Y)-47.19%N/A

Go deeper

Full OKUR analysisFull PLYX analysisInteractive comparison tool

Dig into the metrics

OnKure Therapeutics ROEPolaryx Therapeutics, Inc. Common Stock ROEOnKure Therapeutics operating marginPolaryx Therapeutics, Inc. Common Stock operating marginOnKure Therapeutics revenue growthPolaryx Therapeutics, Inc. Common Stock revenue growthOnKure Therapeutics free cash flowPolaryx Therapeutics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.